Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

New dihydropyridine derivatives with cardiovascular activity from Mercian

Dec. 17, 1997

Sumitomo synthesizes new series of ECE inhibitors

Dec. 17, 1997

Spotlight on ACE inhibitor/calcium antagonist combinations

Dec. 16, 1997

CB1 receptors are activated in hemorrhagic shock

Dec. 16, 1997

Adenovirus-mediated delivery of human tissue kallikrein: novel gene therapy for hypertension

Dec. 15, 1997

E-4010: highly potent and selective PDE V inhibitor from Eisai

Dec. 15, 1997

Phase I trial of oral TBC-11251 successfully completed

Dec. 12, 1997

Effects of BO-653 and related compounds on various active oxygen species

Dec. 12, 1997

Hokuriku describes new calcium agonist derived from intracellular calcium antagonist

Dec. 12, 1997

LXR discovers new apoptosis-related proteins and genes

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...